Aerobactin, but not yersiniabactin, salmochelin, or enterobactin, enables the growth/survival of hypervirulent (hypermucoviscous) Klebsiella pneumoniae ex vivo and in vivo

Infection and Immunity

Volumn 83, Issue 8, 2015, Pages 3325-3333

  Russo, Thomas A ^a,b   Olson, Ruth ^a,b   MacDonald, Ulrike ^a,b   Beanan, Janet ^a,b   Davidsona, Bruce A ^a,b  

^a VA WESTERN NEW YORK HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AEROBACTIN; ENTEROCHELIN; SALMOCHELIN; SIDEROPHORE; UNCLASSIFIED DRUG; YERSINIABACTIN; GLUCOSIDE; HYDROXAMIC ACID; PHENOL DERIVATIVE; SALMOCHELIN S4; THIAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCITES; ASCITES FLUID; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BACTERIUM MUTANT; CONTROLLED STUDY; EX VIVO STUDY; GENE DISRUPTION; HUMAN; IN VIVO STUDY; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SERUM; URINE; WILD TYPE; ANALOGS AND DERIVATIVES; ANIMAL; COMPARATIVE STUDY; DRUG EFFECTS; GENETICS; GROWTH, DEVELOPMENT AND AGING; KLEBSIELLA INFECTION; METABOLISM; MICROBIAL VIABILITY; MICROBIOLOGY; PATHOGENICITY; VIRULENCE; YOUNG ADULT;

ANIMALS; ENTEROBACTIN; GLUCOSIDES; HUMANS; HYDROXAMIC ACIDS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MICE; MICROBIAL VIABILITY; PHENOLS; SIDEROPHORES; THIAZOLES; VIRULENCE; YOUNG ADULT;

EID: 84937799113     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00430-15     Document Type: Article

References (47)

1. Kuehn BM. 2013. "Nightmare" bacteria on the rise in US hospitals, longterm care facilities.JAMA 309:1573-1574. http://dx.doi.org/10.1001/jama.2013.2922.
2. Moellering RC, Jr. 2010. NDM-1-a cause for worldwide concern. N Engl J Med 363:2377-2379. http://dx.doi.org/10.1056/NEJMp1011715.
3. Snitkin ES, Zelazny AM, Thomas PJ, Stock F, Henderson DK, Palmore TN, Segre JA. 2012. Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Sci Transl Med 4:148ra116. http://dx.doi.org/10.1126/scitranslmed.3004129.
4. Centers for Disease Control. 2013. Vital signs: carbapenem-resistant enterobacteriaceae. MMWR Morb Mortal Wkly Rep 62:165-170.
5. Liu YC, Cheng DL, Lin CL. 1986. Klebsiella pneumoniae liver abscess associated with septic endophthalmitis. Arch Intern Med 146:1913-1916. http://dx.doi.org/10.1001/archinte.1986.00360220057011.
6. Shon AS, Bajwa RP, Russo TA. 2013. Hypervirulent (hypermucoviscous) Klebsiella pneumoniae: a new and dangerous breed. Virulence 4:107-118. http://dx.doi.org/10.4161/viru.22718.
7. Cheng DL, Liu YC, Yen MY, Liu CY, Wang RS. 1991. Septic metastatic lesions of pyogenic liver abscess. Their association with Klebsiella pneumoniae bacteremia in diabetic patients. Arch Intern Med 151:1557-1559.
8. Ko WC, Paterson DL, Sagnimeni AJ, Hansen DS, Von Gottberg A, Mohapatra S, Casellas JM, Goossens H, Mulazimoglu L, Trenholme G, Klugman KP, McCormack JG, Yu VL. 2002. Community-acquired Klebsiella pneumoniae bacteremia: global differences in clinical patterns. Emerg Infect Dis 8:160-166. http://dx.doi.org/10.3201/eid0802.010025.
9. Wang JH, Liu YC, Lee SS, Yen MY, Chen YS, Wang JH, Wann SR, Lin HH. 1998. Primary liver abscess due to Klebsiella pneumoniae in Taiwan. Clin Infect Dis 26:1434-1438. http://dx.doi.org/10.1086/516369.
10. Lee HC, Chuang YC, Yu WL, Lee NY, Chang CM, Ko NY, Wang LR, Ko WC. 2006. Clinical implications of hypermucoviscosity phenotype in Klebsiella pneumoniae isolates: association with invasive syndrome in patients with community-acquired bacteraemia. J Intern Med 259:606-614. http://dx.doi.org/10.1111/j.1365-2796.2006.01641.x.
11. Li W, Sun G, Yu Y, Li N, Chen M, Jin R, Jiao Y, Wu H. 2014. Increasing occurrence of antimicrobial-resistant hypervirulent (hypermucoviscous) Klebsiella pneumoniae isolates in China. Clin Infect Dis 58:225-232. http://dx.doi.org/10.1093/cid/cit675.
12. Liu Y, Li XY, Wan LG, Jiang WY, Yang JH, Li FQ. 2014. Virulence and transferability of resistance determinants in a novel Klebsiella pneumoniae sequence type 1137 in China. Microb Drug Resist 20:150-155. http://dx.doi.org/10.1089/mdr.2013.0107.
13. Siu LK, Huang DB, Chiang T. 2014. Plasmid transferability of KPC into a virulent K2 serotype Klebsiella pneumoniae.BMCInfect Dis 14:176. http://dx.doi.org/10.1186/1471-2334-14-176.
14. Yu WL, Ko WC, Cheng KC, Lee CC, Lai CC, Chuang YC. 2008. Comparison of prevalence of virulence factors for Klebsiella pneumoniae liver abscesses between isolates with capsular K1/K2 and non-K1/K2 serotypes. Diagn Microbiol Infect Dis 62:1-6. http://dx.doi.org/10.1016/j.diagmicrobio.2008.04.007.
15. Cheng HY, Chen YS, Wu CY, Chang HY, Lai YC, Peng HL. 2010. RmpA regulation of capsular polysaccharide biosynthesis in Klebsiella pneumoniae CG43. J Bacteriol 192:3144-3158. http://dx.doi.org/10.1128/JB.00031-10.
16. Hsu CR, Lin TL, Chen YC, Chou HC, Wang JT. 2011. The role of Klebsiella pneumoniae rmpA in capsular polysaccharide synthesis and vir- ulence revisited. Microbiology 157:3446-3457. http://dx.doi.org/10.1099/mic.0.050336-0.
17. Wacharotayankun R, Arakawa Y, Ohta M, Tanaka K, Akashi T, Mori M, Kato N. 1993. Enhancement of extracapsular polysaccharide synthesis in Klebsiella pneumoniae by RmpA2, which shows homology to NtrC and FixJ. Infect Immun 61:3164-3174.
18. Brisse S, Fevre C, Passet V, Issenhuth-Jeanjean S, Tournebize R, Diancourt L, Grimont P. 2009. Virulent clones of Klebsiella pneumoniae:identification and evolutionary scenario based on genomic and phenotypic characterization. PLoS One 4:e4982.
19. Miethke M, Marahiel MA. 2007. Siderophore-based iron acquisition and pathogen control. Microbiol Mol Biol Rev 71:413-451. http://dx.doi.org/10.1128/MMBR.00012-07.
20. Hider RC, Kong X. 2010. Chemistry and biology of siderophores. Nat Prod Rep 27:637-657. http://dx.doi.org/10.1039/b906679a.
21. Russo TA, Olson R, Macdonald U, Metzger D, Maltese LM, Drake EJ, Gulick AM. 2014. Aerobactin mediates virulence and accounts for increased siderophore production under iron-limiting conditions by hypervirulent (hypermucoviscous) Klebsiella pneumoniae. Infect Immun 82:2356-2367. http://dx.doi.org/10.1128/IAI.01667-13.
22. Russo TA, Shon AS, Beanan JM, Olson R, Macdonald U, Pomakov AO, Visitacion MP. 2011. Hypervirulent K. pneumoniae secretes more and more active iron-acquisition molecules than "classical" K. pneumoniae thereby enhancing its virulence. PLoS One 6:e26734.
23. Pomakova DK, Hsiao CB, Beanan JM, Olson R, Macdonald U, Keynan Y, Russo TA. 2012. Clinical and phenotypic differences between classic and hypervirulent Klebsiella pneumoniae: an emerging and underrecognized pathogenic variant. Eur J Clin Microbiol Infect Dis 31:981-989. http://dx.doi.org/10.1007/s10096-011-1396-6.
24. Russo TA, Gill SR. 2013. Draft genome sequence of the hypervirulent Klebsiella pneumoniae strain hvKP1, isolated in Buffalo, New York. Genome Announc 1:e0006513.
25. Luke NR, Howlett AJ, Shao J, Campagnari AA. 2004. Expression of type IV pili by Moraxella catarrhalis is essential for natural competence and is affected by iron limitation. Infect Immun 72:6262-6270. http://dx.doi.org/10.1128/IAI.72.11.6262-6270.2004.
26. Russo TA, MacDonald U, Beanan JM, Olson R, MacDonald IJ, Sauberan SL, Luke NR, Schultz LW, Umland TC. 2009. Penicillinbinding protein 7/8 contributes to the survival of Acinetobacter baumannii in vitro and in vivo. J Infect Dis 199:513-521. http://dx.doi.org/10.1086/596317.
27. Chakravarthy KV, Davidson BA, Helinski JD, Ding H, Law WC, Yong KT, Prasad PN, Knight PR. 2011. Doxorubicin-conjugated quantum dots to target alveolar macrophages and inflammation. Nanomedicine 7:88-96. http://dx.doi.org/10.1016/j.nano.2010.09.001.
28. National Research Council. 2011. Guide for the care and use of laboratory animals, 8th ed. National Academies Press, Washington, DC.
29. Tu YC, Lu MC, Chiang MK, Huang SP, Peng HL, Chang HY, Jan MS, Lai YC. 2009. Genetic requirements for Klebsiella pneumoniae-induced liver abscess in an oral infection model. Infect Immun 77:2657-2671. http://dx.doi.org/10.1128/IAI.01523-08.
30. Lv H, Hung CS, Henderson JP. 2014. Metabolomic analysis of siderophore cheater mutants reveals metabolic costs of expression in uropathogenic Escherichia coli. J Proteome Res 13:1397-1404. http://dx.doi.org/10.1021/pr4009749.
31. Bachman MA, Lenio S, Schmidt L, Oyler JE, Weiser JN. 2012. Interaction of lipocalin 2, transferrin, and siderophores determines the replicative niche of Klebsiella pneumoniae during pneumonia. mBio 3:e00224-11. http://dx.doi.org/10.1128/mBio.00224-11.
32. Bachman MA, Oyler JE, Burns SH, Caza M, Lepine F, Dozois CM, Weiser JN. 2011. Klebsiella pneumoniae yersiniabactin promotes respiratory tract infection through evasion of lipocalin 2. Infect Immun 79:3309-3316. http://dx.doi.org/10.1128/IAI.05114-11.
33. Chan YR, Liu JS, Pociask DA, Zheng M, Mietzner TA, Berger T, Mak TW, Clifton MC, Strong RK, Ray P, Kolls JK. 2009. Lipocalin 2 is required for pulmonary host defense against Klebsiella infection. J Immunol 182:4947-4956. http://dx.doi.org/10.4049/jimmunol.0803282.
34. Flo TH, Smith KD, Sato S, Rodriguez DJ, Holmes MA, Strong RK, Akira S, Aderem A. 2004. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 432:917-921. http://dx.doi.org/10.1038/nature03104.
35. Neilands JB. 1981. Microbial iron compounds. Annu Rev Biochem 50:715-731. http://dx.doi.org/10.1146/annurev.bi.50.070181.003435.
36. Perry RD, Balbo PB, Jones HA, Fetherston JD, DeMoll E. 1999. Yersiniabactin from Yersinia pestis: biochemical characterization of the siderophore and its role in iron transport and regulation. Microbiology 145:1181-1190. http://dx.doi.org/10.1099/13500872-145-5-1181.
37. Weinberg ED. 1978. Iron and infection. Microbiol Rev 42:45-66.
38. Braun V, Brazel-Faisst C, Schneider R. 1984. Growth stimulation of Escherichia coli in serum by iron(III) aerobactin. Recycling of aerobactin. FEMS Microbiol Lett 21:99-103. http://dx.doi.org/10.1111/j.1574-6968.1984.tb00193.x.
39. Konopka K, Bindereif A, Neilands JB. 1982. Aerobactin-mediated utilization of transferrin iron. Biochemistry 21:6503-6508. http://dx.doi.org/10.1021/bi00268a028.
40. Konopka K, Neilands JB. 1984. Effect of serum albumin on siderophoremediated utilization of transferrin iron. Biochemistry 23:2122-2127. http://dx.doi.org/10.1021/bi00305a003.
41. Hsieh PF, Lin TL, Lee CZ, Tsai SF, Wang JT. 2008. Serum-induced iron-acquisition systems and TonB contribute to virulence in Klebsiella pneumoniae causing primary pyogenic liver abscess. J Infect Dis 197:1717-1727. http://dx.doi.org/10.1086/588383.
42. Chen YT, Chang HY, Lai YC, Pan CC, Tsai SF, Peng HL. 2004. Sequencing and analysis of the large virulence plasmid pLVPK of Klebsiella pneumoniae CG43. Gene 337:189-198. http://dx.doi.org/10.1016/j.gene.2004.05.008.
43. Wu KM, Li LH, Yan JJ, Tsao N, Liao TL, Tsai HC, Fung CP, Chen HJ, Liu YM, Wang JT, Fang CT, Chang SC, Shu HY, Liu TT, Chen YT, Shiau YR, Lauderdale TL, Su IJ, Kirby R, Tsai SF. 2009. Genome sequencing and comparative analysis of Klebsiella pneumoniae NTUHK2044, a strain causing liver abscess and meningitis. J Bacteriol 191:4492-4501. http://dx.doi.org/10.1128/JB.00315-09.
44. Nassif X, Fournier JM, Arondel J, Sansonetti PJ. 1989. Mucoid phenotype of Klebsiella pneumoniae is a plasmid-encoded virulence factor. Infect Immun 57:546-552.
45. Lawlor MS, O'Connor C, Miller VL. 2007. Yersiniabactin is a virulence factor for Klebsiella pneumoniae during pulmonary infection. Infect Immun 75:1463-1472. http://dx.doi.org/10.1128/IAI.00372-06.
46. Bearden SW, Perry RD. 1999. The Yfe system of Yersinia pestis transports iron and manganese and is required for full virulence of plague. Mol Microbiol 32:403-414. http://dx.doi.org/10.1046/j.1365-2958.1999.01360.x.
47. Garcia EC, Brumbaugh AR, Mobley HL. 2011. Redundancy and specificity of Escherichia coli iron acquisition systems during urinary tract infection. Infect Immun 79:1225-1235. http://dx.doi.org/10.1128/IAI.01 222-10.